HALEON PLC-ADR
HLN · NYSE
Updated at 2026-10-14 08:10:33
- Today's High
- $9.59
- Today’s Low
- $9.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $9.35
- Previous Close
- $9.50
- Volume
- 19.37M
- Market Cap
- $30.71B
- P/E Ratio
- 18.92X
- EPS
- $0.18
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- THE HEIGHTS, WEYBRIDGE, UNITED KINGDOM, KT13 0NY
- Country
- GB
- Listing Date
- 2022-07-18
- Fiscal Year End
- December
- Shares Outstanding
- 8.8B
- CIK
- 0001900304
- Website
- www.haleon.com
Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline, dedicated to providing innovative health solutions through a robust portfolio of trusted brands, including Sensodyne, Panadol, and Voltaren. Focused on key segments such as oral care, pain relief, and dietary supplements, Haleon addresses evolving consumer needs while leveraging strong brand equity for sustained market presence. The company's commitment to sustainability and ongoing innovation, alongside strategic investments in product development, positions Haleon favorably for long-term growth and enhanced health outcomes, ultimately maximizing value for shareholders.
Financial Metrics
Revenue
2026-06-30
$5.64B
2025-12-31
$5.51B
2025-06-30
$5.48B
2025-03-31
$2.74B
Operating Expenses
2026-06-30
$2.38B
2025-12-31
$2.33B
2025-06-30
$2.33B
2025-03-31
$1.16B
Net Income
2026-06-30
$767.62M
2025-12-31
$855.69M
2025-06-30
$806M
2025-03-31
$403M
Net Profit Margin
2026-06-30
13.6%
2025-12-31
15.51%
2025-06-30
14.7%
2025-03-31
14.7%
Earnings Per Share
2026-06-30
--
2025-12-31
--
2025-06-30
$0.09
2025-03-31
$0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.51B
2025-12-31
$1.43B
2025-06-30
$1.39B
2025-03-31
$667M
Effective Tax Rate
2026-06-30
27.08%
2025-12-31
19.49%
2025-06-30
24.37%
2025-03-31
24.37%
| Item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $5.64B | $5.51B | $5.48B | $2.74B |
| Operating Expenses | $2.38B | $2.33B | $2.33B | $1.16B |
| Net Income | $767.62M | $855.69M | $806M | $403M |
| Net Profit Margin | 13.6% | 15.51% | 14.7% | 14.7% |
| Earnings Per Share | -- | -- | $0.09 | $0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.51B | $1.43B | $1.39B | $667M |
| Effective Tax Rate | 27.08% | 19.49% | 24.37% | 24.37% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.